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Summary 
Sdectins represent a new family of adhesion molecules, expressed by leukocytes and endothelial 
cells, that are involved in the regulation of leukocyte traffic. Here we have characterized a new 
monoclonal antibody (mAb) (EI.-246) that recognizes both human leukocyte I~selectin  (previously 
called LAM-1, LECAM-1, or gpgOMEI:14)  and endothelial cell E-sdectin (previously  called  ELAM- 
1). Eb246 recognized a 110-kD protein expressed on cells transfected with E-sdectin c.DNA 
and stained many postcapillary venules in inflamed human tonsil. EL-246 also stained human 
peripheral blood leukocytes and showed identity with anti-bsdectin mAb in two-color flow 
cytometric analysis. The expression of the leukocyte EI.-246 antigen was regulated in the same 
manner as I..selectin and EL,246 recognized anti-L-selectin mAb affinity-purified antigen in 
SDS/PAGE Western blot analysis. Further, L,  selectin cDNA transfectants were specifically  stained 
by EL-246. EL-246 blocked >95%  of lymphocyte adhesion to peripheral lymph node high 
endothelial venules and >90% of neutrophil adhesion to E-sdectin transfectants. In addition 
to the ED246 epitope being expressed on two different human selectins, it was detected on 
L-selectin from a variety of different animals. Interestingly, domain mapping studies localized 
the Eb246 epitope to the short consensus repeat (SCR) domains of Lsdectin. EL246 is the 
first mAb that recognizes  two different sdectins and potentially defines  a functional epitope encoded 
by the SCR domains. Inhibitors of selectin function targeted to this region would be expected 
to have the added advantage of simultaneously blocking the activity of two distinct adhesion 
proteins involved in inflammation. 
S 
electins, previously called LEC-CAMs,  represent a new 
family of adhesion proteins that regulate leukocyte entry 
into lymphoid tissues and sites of inflammation (1, 2). Three 
members of this  family  have been identified:  E-sdectin 
and P-sdectin (originally termed ELAM-1 and GMP-140/ 
PADGEM, respectively), expressed by endothelial cells; and 
bsdectin (also called LAM-1, LECAM-1, Len-8, TQ-1, or 
peripheral lymph node homing receptor), expressed by vir- 
tuaUy all PBLs. P-Selectin is a cytoplasmic glycoprotein in 
endothelial calls and platdets that can be rapidly (within 
minutes) translocated to the cell surface upon activation with 
thrombin (3-5). E-Selectin is also an inducible endothdial 
cell surface glycoprotein, but requires 2-4 h for expression, 
reflecting the requirement for de novo protein and RNA syn- 
thesis (6, 7). Both P- and E-selectin are adhesion proteins 
for neutrophils and monocytes (3, 4, 6, 7). A subpopulation 
of memory T cells has also been shown to bind E-sdectin 
(8, 9). In contrast to the vascular sdectins, bselectin is con- 
stitutively expressed by leukocytes and mediates lymphocyte 
adhesion to peripheral lymph node high endothdial venules 
(HEV) t by binding the peripheral vascular addressin (10, 11), 
and neutrophil adhesion to cytokine-activated  endothelial cells 
(12-14). Recently, neutrophil l.-selectin has been shown to 
be a potential counter-receptor  for E-selectin (15, 16). 
At the molecular level, all three selectins exhibit a unique 
mosaic structure consisting of an NH2-terminal type-c lectin 
domain, an epidermal growth factor (EGF)-like domain, and 
multiple short consensus repeat (SCR) domains homologous 
to those found in complement regulatory  proteins  (4,  6, 
17-20). Overall these proteins share 40-60% identity at the 
nucleotide and amino acid level, and may have arisen by gene 
I Abbreviations used in this  patx,  r: EGF, epidermal growth factor; HEV, high 
endothelial venuh;  SCR, short consensus repeat. 
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of each selectin are believed to be critical to the adhesive func- 
tions of the proteins, and the carbohydrate binding specificides 
of all  three  selectins  have  been  partially defined.  P-  and 
E-sdecdn both recognize sialylated Lewis  x  (sLex), which 
decorates glycoproteins and glycolipids expressed by myeloid 
cells although differences  in their binding properties exist 
(21-25). bSdectin function is blocked by certain simple sugars, 
such as mannose-6-PO4, and certain complex polysaccharides, 
such as the mannose-6-PO4-rich phosphomannan (PPME) 
from the yeast Hansenuta hotstii (26, 27, and reviewed in ref- 
erence 1). Furthermore, many antibodies that block bsdectin 
function recognize epitopes encoded by the lectin domain 
(28-30). 
Other spatially separate and distinct functional domains 
of the selectins may also exist. Antibodies against the mouse 
or human L,  selectin EGF domain block lymphocyte adhe- 
sion to HEV but have little effect on carbohydrate binding 
(29, 31). Studies of chimeric bselectin/Ig constructs suggest 
that the SCR domains also have important functional roles 
for sdectins (32),  but,  in contrast to the lectin and EGF 
domains, no function blocking antibody has been shown 
to recognize this region. In addition, it is thought that the 
functional role of the SCKs is restricted to maintenance of 
proper molecular conformation, which is distinct for each 
sdectin (32). 
Here we characterize  a new mAb (Eb246) that recognizes 
a common epitope expressed on both human E- and L,  sdecdn. 
EL-246 blocks  the  function of both  proteins,  recognizes 
sdectins from a variety of different animals, and its epitope 
is encoded or at least controUed by the selecdn SCK domains. 
These results show that antibodies against the SCR domains 
can inhibit the adhesive function of two distinct sdectins. 
Insight into the generation of novel therapeutics, designed 
to inhibit the function of two adhesion proteins involved in 
inflammation, may be gained by further study of the EL-246 
epitope. 
Materials and Methods 
Animals.  The animals  as sources  of  blood (see below) were ran- 
domly selected from the large animal ~cilities at Montana State 
University. No large animal experiments were performed. Both 
BALB/C and C57BL/6 mouse strains were used. The mice ranged 
in age from 6 to 12 wk and were used primarily for the generation 
of mAbs or as sources of lymphoid tissues. The mice were housed 
in the small animal facility at Montana State University, which 
is AAALAC approved. 
Leul~ocyte Cell Suspensions.  Leukocytes  were harvested  from the 
peripheral blood of humans, goats, sheep, cattle, horses, pigs, rats, 
and chickens.  For routine immunofluorescence  staining, RBCs (ex- 
cept chicken RBCs) were lysed  in a hypotonic solution. Human 
blood was used as a source of lenkocytes for the functional assays 
described below. We used previously described methods to isolate 
both mononuclear cells  and neutrophils 0 0, 33-35). Briefly,  blood 
was collected  into citrate anticoagulent  tubes, diluted 1:2 with warm 
HBSS, underhyed with Histopaque 1077, and centrifuged at 2,300 
KPM for 30 min at room temperature. Mononuclear cells were 
collected from the Histopaque/plasma interface. The pellet, which 
included KBCs and neutrophils, was resuspended to its original 
volume in HBSS and the neutrophils isolated by Dextran sedimen- 
tation. Residual RBCs in both the mononuclear cell and neutro- 
phfl preparations were lysed by hypotonic treatment. 
mAbs.  Len-8  (purchased from Becton Dickinson & Co., Moun- 
tain View, CA) and the DREG series of  mAbs (DREG 56, DREG 
200, and DREG 152), which are mouse IgGs that have  been shown 
to recognize human bsdectin (19, 30), were used in the flow cyto- 
metric and Western blot analysis  described below. Leu-8 was used 
as a PE conjugate, and the DREG mAbs were used as unconjugated 
mAbs followed  by appropriate second  stage or as FITC conjugates. 
The DREG mAbs were partially purified by ammonium sulphate 
precipitation. Other mAbs, SH43 (mouse IgG1 anti-sheep platelet; 
M. A. Jutila, unpublished observations) and Eb81 (mouse IgG1 
anti-ELAM-1), were used as negative controls in many of the ex- 
periments described below. 
Immunization and mAb Generation.  Mouse  L1-2 lymphoma cells 
stably expressing  human E-selectin  cDNA (L1-2 ELAM) (16) were 
used as immunogen for the generation of anti-E-selectin antibodies. 
Briefly, L1-2ELAM  ceils (2  x  107) were injected intraperitoneally 
into C57BL/6 mice at biweekly intervals (a total of three injec- 
tions) in the absence of adjuvant. Serum titers were tested by flow 
cytometry for staining of the L1-2ELAM and E-selectin cDNA- 
transfected  L cells (see below). The last boost was done 4 d before 
the fusion. The SP2/0 myetoma  cell  line was used as a fusion partner, 
and previously described procedures were followed in the genera- 
tion of hybridomas (30). The fusion was screened on day 10 by 
flow cytometry using E-selectin-transfected  and mock-transfected 
L1-2 cells. A total of 279 cells were screened and 15 selected for 
further analysis. Secondary screens included SDS/PAGE Western 
blot analysis,  immunohistology, and staining of  PBLs. As described 
below, Eb246, which is a mouse IgG1, was found to stain both 
E-selectin transfectants and human leukocytes. 
Irnmunofluorescence Staining and Flow Cytometric Analysis.  Im- 
munofluorescence  staining  of  leukocytes  was carded out as described 
(33-35). Briefly, 106 cells were initially incubated in 2% rabbit 
serum for 10 min on ice to block Fc receptors. The cells  were washed 
and then incubated with primary antibody at 50 #g/m1 (or un- 
diluted culture supernatant) for 20 rain on ice. After washing,  bound 
antibodies were revealed  by incubation  with PE- or FITC-conjugated 
F(ab')2 goat anti-mouse Ig (Tago Inc., Burlingame, CA) at a 1:80 
dilution in 5% FCS in DMEM. Flow cytometric analysis  was per- 
formed on a FACScan  |  (Becton Dickinson & Co.) as described 
(33-35). For two-color analysis,  PE-conjugated  Leu-8 (Becton  Dick- 
inson & Co.) or a FITC-conjugated DREG mAbs were used in 
combination with EL-246. The ceils stained  with second stage were 
treated with 10% mouse serum to block any available anti-mouse 
Ig binding sites, and negative control mouse mAbs were used to 
evaluate the level  of  background staining. Data were collected  from 
1-5  x  104 cells and are presented as histograms or contour plots. 
In Vitro PMA  Treatment of PBLs.  Isolated  PBMC from the 
animals listed above were incubated with PMA (10 ng/ml; Sigma 
Chemical Co., St. Louis, MO) for 20 min at 37~  in HBSS. After 
the incubation period, the cells were washed and stained for flow 
cytometric analysis. 
Peripheral Lymph Node HEV Assay.  The in vitro assay  of lym- 
phocyte binding to HEVs in frozen sections (36) has been exten- 
sively  described (recently reviewed in reference 10). We have previ- 
ously shown that HEV in mouse peripheral lymph nodes bind 
human lymphocytes well, and this binding  is dependent upon 
L-selectin (30). Purified human lymphocytes were incubated with 
cuhure  supernatants of EL-246, a blocking anti-L-selectin  mAb 
(DREG 56), or different isotype controls, and the effect on adhe- 
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quantitated by first identifying HEVs in each field by their charac- 
teristic autofluorescence or unique plump morphology and then 
counting cells bound to HEV, as described (30). Data were calcu- 
lated as number of cells bound per individually scored HEV. For 
each data point,  >150 HEVs in more than three sections were 
counted and are from four independent experiments. Values are 
presented as percentage of medium control. 
Neutrophil-E-Selectin Transfectant  Binding Assay.  L cells stably ex- 
pressing human E-selectin cDNA (80% ELAM-1 positive deter- 
mined by flow cytometry), previously described by Kishimoto et 
al., (15), were grown on plastic eight-well Lab Tek slides (Miles 
Scientific, Naperville, IL). Neutrophils isolated from human pe- 
ripheral blood were resuspended at 10  e cells/ml in cRPMI, and 
400 #1 was added to the wells of the transfected L cell cultures. 
The neutrophils were allowed to adhere at room temperature for 
15 min under constant rotation, as previously  described (15). After 
the incubation,  the medium in  each well was aspirated, slide 
chambers were removed, and the slides were placed in a coplin jar 
with 1.0% glutaraldehyde in HBSS. Adhesion was measured by 
counting the number ofneutrophils/L cell. The effect  ofmAb treat- 
ment of the L cells was determined as follows. In all experiments 
the neutrophils were precoated with 10% rabbit serum to block 
available Fc binding sites. The E-selectin transfectants were treated 
with EL-246 (culture supernatant) or an isotype-negative control 
mAb for 20 rain at room temperature, washed, and then used in 
the adhesion assay. 
SDS-PAGE Western Blot Analysis.  Lysates  of human PBL or 
L1-2ELAM cell suspensions were prepared by incubating 3  x  10  r 
cells in 1.0 ml of NP-40 lysis buffer (3% NP-40, 150 mM NaCI, 
1 mM MgCI2, 5 mM EDTA, 0.02% NAN3, and 10/~g/ml of the 
following protease inhibitors: lmpstatin A,  antipain, leupeptin, 
chymostatin, benzamidine, and PMSF; all in 50 mM Tris-HCl, 
pH 7.5) for 30 min on ice. Lysates  were clarified  by centrifugation 
at 10,000 g for 10 min at 4~  and either used in affinity  purification 
or directly in SDS-PAGE Western blot analysis. 
For affinity  isolation, CNBR-activated  Sepharose  4]} beads (Phar- 
macia Fine Chemicals, Piscataway,  NJ) were coupled to the appro- 
priate mAb (4 mg of mAb/ml of beads) according to manufac- 
turer's  instructions  (Pharmacia  Fine  Chemicals) using  poly 
preparatory chromatography  columns (Bio-Rad  Laboratories,  Rich- 
mond, CA). 1 ml of lysate containing the antigen of interest was 
mixed with 3 ml of wash buffer (150 mM NaC1, 1 mM MgClz, 
0.1% NP-40, 5 mM NAN,, 20 mM Tris buffer, pH 7.5) and com- 
bined with the beads described above on a rotator for 2 h at 40C. 
After the incubation, the beads were washed with 10 ml of wash 
buffer to remove any unbound antigen. Bound antigen was duted 
with 3 ml of elution buffer (500 mM NaC1, 0.1% NP-40, 5 mM 
NAN,, 200 mM acetic acid) and eluents collected in 0.5-ml frac- 
tions and neutralized with 100/xl of 1 M Tris buffer, pH 8.0. Frac- 
tions containing proteins of interest were determined by dot-blot 
analysis. 
For SDS/PAGE Western blot analysis,  crude lysates  or affinity- 
purified antigen were mix~ with equal volumes  of2x nonreducing 
SDS-solubilization  buffer (samples were not boiled), run on an 8% 
SDS/PAGE gel, and transferred to nitrocellulose at 40C with a 
transblot apparatus per manufacturer's directions (Bio-Rad  Labora- 
tories). The mild nondenaturing conditions (no boiling and most 
procedures done at 40C) were required in the analysis  of  L-sdectin. 
Filters were incubated with 50% horse serum in TBST (10 mM 
Tris-HC1, pH 7.4, 150 mM NaCI, and 0.05% Tween-20) for 30 
rain. Using a 25-Iane mini-blot apparatus (Immunonetics, Cam- 
bridge, MA), the filters were then incubated for 60 rain with ei- 
ther specific or negative control mouse mAb at 50-#g/ml concen- 
trations or as culture supematant fluid. The nitrocellulose filters 
were then washed in TBST, incubated with goat anti-mouse Ig- 
alkaline phosphatase conjugate (A-9654; Sigma Chemical Co.), 
diluted 1:200, and then washed again. The blots were developed 
by addition of substrate solution (Promega  Biotech, Madison, WI). 
Immuno~roxidase Staining.  Acetone-fixed  6-#m frozen sections 
were incubated with antibodies in PBS (50 #g/ml) for 30 win at 
room temperature in a humidified chamber, and then washed in 
PBS. Using a histochemical  kit (Histoprobe; Tago Inc., Burlingame, 
CA), a three-stage immunoperoxidase stain using an avidin biotin 
system was done per manufacturer's instructions. Sections were 
lightly counterstained with hematoxylin. 
Domain Mapping of the EL246 Epitope.  The epitope defined  by 
the EL-246 mAb was localized using previously described (29) 
L-selectin/P-selectin chimeras. Stable transfectants of the 300.19 
mouse pre-B cell (37) expressing either: (a) native L-selectin; (b) 
L2P, which contains the lectin domain from L-selectin  and the re- 
mainder of the protein from P-selectin; or (c) L2P3L, in which 
the selectin SCR domains have been substituted for the P-selectin 
SCR domains  in L2P, were produced as described  elsewhere  (Kansas 
et al., manuscript in preparation). 5 x  10  s cells of each type were 
incubated on ice for 15 rain in 100/zl of culture supernatants or 
PBS/1% FCS containing diluted ascites of the indicated mAb, 
washed, and incubated with FITC-conjugated goat anti-mouse Ig 
(Tago Inc.). The ceils were then washed  and analyzed  by flow cytom- 
etry on an EPICS Profile (Coulter Immunology, Hialeah, FL). 
Results 
EL,246 Recognizes Human E-SeIectin.  EIr246 was initially 
screened on human E-selectin cDNA-transfected mouse L1-2 
cells by flow cytometry and SDS/PAGE Western blot.  As 
shown in Fig. 1, E-seleetin-transfected, but not the mock- 
transfected, L1-2 cells stained brightly with Eb246 in flow 
cytometric analysis. The molecular mass of the antigen ex- 
pressed by the transfectants recognized by EL-246 was --110 
kD under nonreducing SDS/PAGE Western blot (Fig.  2). 
EL-246 also recognized E-selectin cDNA-transfected L cells, 
but did not recognize P-seleetin cDNA-transfected cells (data 
not shown, and see below). As shown in Fig. 3, EI~246 stained 
many venules in inflamed human tonsil (Fig. 3), indicating 
the antibody did not recognize an artifact of the transfec- 
rants. Therefore, EL-246 clearly recognized human E-sdectin. 
EI.,246 Recognizes Human LSelectin.  Plow cytometric anal- 
ysis showed that Eb246 also stained human PBL (Fig.  4). 
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Figure  1.  ED246 stains L1-2 
cells transfected  with human  E-se- 
lectin cDNA. Human E-selectin 
cDNA-transfected and  mock- 
transfected  mouse LI-2 cells  were 
stained  with EL-246  for flow  cyto- 
metric analysis.  Arrows point to 
histograms that represent (1) Eb 
246 staining  of  L1-2ELAM  and (2) 
L1-2 transfectant  controls,  and (3) 
background staining  (second  stage 
control) of the L1-2ELAM  trans- 
fectants. 
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kD antigen expressed  by L1-2ELAM 
cells. L1-2ELAM  NP40 lysates  were 
run on a norLreducing 8% SDS gel 
and transferral to nitrocellulose. The 
blots were probed with EL-81 (anti- 
E-selectin, lane I), E1r  (lane 2), 
and negative control antibody (lane 
3). The distance of migration of the 
molecular mass markers is  as  in- 
dicated. 
EL-246 stained all circulating human neutrophils and a sub- 
population of lymphocytes, which is the same distribution 
pattern described for bselectin (30, 38).  In two-color flow 
cytometry, all EL'246-positive cells were shown to be DREG 
56 (anti-bselectin mAb [30]) positive, and the staining pat- 
terns of the two antibodies were similar (Fig. 5). The human 
leukocyte EL'246 antigen was lost from the cell surface after 
activation of neutrophils  and lymphocytes with PMA (Fig. 
4), which is also characteristic of L'selectin. Cells transfected 
with human bselectin eDNA, but not the transfectant con- 
trols,  were  specifically  stained  with  EL-246  (see  below), 
providing direct evidence that EL'246 stains bselectin. Fur- 
thermore,  EL'246  recognized  af~nity-purified  L'selectin in 
Western blots (Fig.  6). Therefore, by biochemical and mo- 
lecular  criteria,  EL'246 reacted with L'selectin. 
The EL-246 Epitope Is Expressed on Selectins  from a Variety 
of Different Animals.  To evaluate the level  of evolutionary 
conservation of the EL-246 epitope, peripheral blood cells from 
a variety of different animals were screened for EL,246 staining 
by flow cytometry. As shown in Table 1, EL'246 stained leu- 
kocytes isolated from humans, goats, sheep, cattle, and pigs. 
Chicken and rat leukocytes were EL'246 negative by flow cyto- 
lalgnare 3.  EL.246  recognizes inflamed venules in frozen sections of human tonsil. Frozen sections of human tonsil were prepared as described  in 
Materials and Methods and stained by immunoperoxidase  with Eb246. Arrows point to positive staining endothelial cells, x200. 
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Figure 4.  Eb246 recognizes a human PBL surface antigen that is down- 
regulated  after treatment with PMA. Human PBL were isolated  as de- 
scribed in Materials and Methods and stained with Eb246 for flow c/to- 
metric analysis. The expression of the Eb246 antigen on neutrophils  and 
lyraphocytes,  which were identified by their distinctive  forward  and side 
light scatter profiles, is shown in the representative  histograms.  A com- 
parison of the staining  before (untreated)  and 20 min after PMA activa- 
tion (PMA-treated)  is shown. Background  fluorescence with an isotype 
control or second stage alone gave a mode fluorescence value of <10 in 
each analysis. 
metric analysis, which was also confirmed by lack of staining 
of cytospin preparations.  The antigen recognized by Eb246 
in these other animals had the characteristic distribution of 
L-selectin, with lymphocytes exhibiting a bimodal distribu- 
tion and its surface expression lost after the cells were treated 
with PMA (data not shown). 
EL,246 Blocks the Function of  Both LSelectin and E-Selectin. 
The ability of EL-246 to block E- and L-selectin function was 
tested. The function universally attributed to bselectin is the 
adhesion of lymphocytes to HEV cells in peripheral lymph 
nodes (1, 10). Using the Stamper and Woodruff  ex vivo frozen 
section binding assay (36), we found that EL246 blocked lym- 
phocyte adhesion to peripheral lymph node HEV equally as 
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Figure 5.  EI.-246  costains with 
anti-bselectin  antibodies.  Two- 
color flow cytometric staining was 
done using FITC-hbeled DREG 
56 (anti-bselectin mAb (30) and 
Eb246 as described in Materials 
and Methods.  A contour plot is 
shown that demonstrates  that all 
EL-246 cells  are  also  L-selectin 
positive. 
Figure  6.  Eb246  recognizes 
~flh~ity  purified bsdectin in West- 
ern blots,  bsdectin was affanity 
purified ruing the DILEG 56 anti- 
L-selectin mAb  as  described  in 
Materials and Methods, run on an 
8% SDS gel under nonredueing 
conditions, transferred to nitrocel- 
lulose,  and  probed with ED246 
(lane  2),  another  anti-bsdectin 
mAb (DREG  152) (lane  3),  or 
second-stage control (lane 1). The 
migration of the molecular  mass 
markers  was as indicated. 
well or perhaps  better than our previous  blocking anti-L- 
sdectin mAb,  DREG 56  (95.6  +  4.8%  vs.  88  •  5.1% 
blocking, respectively)  (Fig. 7). Control m_Abs, including some 
generated in the same fusion that yielded EL-246, had no effect 
on lymphocyte-HEV binding (Fig. 7). EL.246 did not sig- 
nificantly block the binding of FITC-PPME to human lym- 
phocytes  (data not shown), another function mediated by 
L-sdectin (1). These results are similar to the blocking activity 
of mAbs directed to the EGF domain of bsdectin (29, 31). 
Table  1.  The EL-246 Etritope Is  Conserved on Leukocytes 
from a  Variety  of Different  Animals 
Staining of PBL* 
Animal  DREG  56  EL-246 
Human  +  + 
Cow  +  + 
Sheep  -  + 
Goat  -  + 
Pig  -  + 
Horse  -  - 
Rat  -  - 
Chicken  -  - 
* PBL were harvested  from each animal  as described  in Materials  and 
Methods and  stained  with EL-246 and  DKEG 56 for flow cytometric 
analysis. Positive reactivity was staining that was above background  nega- 
tive control antibody staining. 
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Figure 7.  Eb246 blocks the function of L-selectin and E-sdectin.  (A) 
The Stamper and Woodruff ex vivo lymph node HEV binding assay (36) 
was used to measure L-selectin  function. Human lymphocytes were treated 
with culture supernatants  of Eb246, DREG 56, or an isotype-matched 
negative control (EBB1), for 20 rain on ice, and the effect on binding to 
peripheral lymph node HEV was determined.  (B) Neutrophil adhesion 
to E-selectin cDNA-transfected L cells was used to measure the effect of 
EL-246 On E-selectin function. The transfectants were treated with Eb246 
(culture supernatant),  CL2 (blocking anti-E-selectin mAb [25/~g/ml]), 
or an isotype-negative control (Eb81 culture supernatant)  for 20 min, 
washed, and the effect on binding  to human neutrophils determined. Values 
were recorded as percentage of control cell binding, where controls cells 
were incubated in assay medium alone. The experiments were repeated 
four times, and the means  +  SEM are presented. 
fectants (>90%), whereas another mAb (Eb81) generated 
in the same fusion as EL,246 and recognized E-selectin had 
little effect on binding. CL2  (anti-E-sdectin) had similar 
blocking effects to those seen in our previous report (15) (Fig. 
7).  Therefore,  Eb246  is an effective blocker of E-sdectin 
function. 
Mapping of the EL246 Epitope to the SCR Domains.  The 
pattern of binding of EL,246 mAb to L,sdectin/P-sdectin 
chimeras was used to determine the domain of L,selectin in 
which the Eb246 epitope resides. As controls, we used the 
LAM1-3, LAMI-1, and LAMl-14 mAbs, which define epi- 
topes within the lectin, EGF, and SCK domains of bselectin, 
respectively  (29, 39), and the AC1.2 mAb (40), which identifies 
an epitope in the SCK domains of P-sdectin (1). Eb246 
specifically  recognized the native L,sdectin transfectants (Fig. 
8), confirming that EL,246 recognizes L,selectin. P,  eplacement 
of the EGF and SCK domains of L,sdectin with those of 
P-selectin (L2P) abolished EL,246 binding (Fig. 8), demon- 
strating that the EL,246 epitope is not within the lectin do- 
main of L,selectin. Furthermore, substitution of only the 
L,sdectin SCK domains back into the L2P construct (L2P3L) 
restored EL,246 binding (Fig. 8). These data indicate  that 
at least part of the EL,246 epitope is within, or requires, the 
SCK domains of L-sdectin. Additional data in support of these 
results are that EL,246 does not block the lectin activity of 
L-sdectin or cross-block the binding of four mAbs (DILEG 
200, DILEG 55, DILEG 56, and Leu-8) that recognize the 
L,selectin domain (data not shown). 
To examine the effect of Eb246 on E-selectin function, 
the ability of neutrophils to bind L cells stably expressing 
E-selectin was tested. In this binding assay the adhesion of 
neutrophils to the transfectants is dearly E-sdectin depen- 
dent (15). The transfectants were treated with Eb246 for 30 
rain and washed before addition of purified human neutro- 
phils,  as described in Materials and Methods. Fc receptors 
were saturated by pretreating the nentrophils with 10% ILSS 
for 20 rain before the assay. As shown in Fig. 7, EL,246 nearly 
completely blocked the binding of neutrophils to the trans- 
neg  r  LAMI-3  LAMI-1 
Discussion 
Selectins represent a new family of adhesion proteins that 
are important for leukocyte migration into tissues. These pro- 
teins mediate neutrophil and monocyte adhesion to inihmed 
endothelial cells (1-7, 12-16) and migration into inflammatory 
sites in vivo (33, 35, 41-44),  and lymphocyte homing into 
peripheral lymphoid tissues (reviewed in reference 10). P- and 
E-selectin, are expressed by endothelial ceUs, while I.-selectin 
is restricted to leukocytes. Here we provide the characteriza- 
tion of a mAb (EL,246) that recognizes a common epitope 
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Figure 8.  The Eb246 epitope is located in the SCR domains of L-selectin. Expression of the Eb246 epitope was assessed on native I~selectin and 
on chimeric selectins expressing the lectin domain of L-selectin  with the remainder of the protein as P-sdectin (L2P); or L-selectin  with the EGF domain 
of P-sdectin substituted for that of bselectin (L2P3L). Analysis was carried out by flow cytometry as described in Materials and Methods. Included 
for comparison are the LAM1-3, Lain1-1, and LAMl-14 mAbs, which are directed against the lectin, EGF, and SCR domains of bselectin, respectively; 
and AC1.2 mAb, directed against the SCR domains of P-selectin. EL246 stained only those selectins containing the SCR domains of L-selectin. 
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cells transfected with E-  and L-selectin cDNAs as well as 
inflamed endothelial cells and PBLs. The leukocyte EL,246 
epitope is regulated like L-selectin and Eb246 shows identity 
with another anti-I,  selectin mAb in two-color flow cytometric 
staining. Analysis of crude lysates and purified EL-246 an- 
tigen confirmed the reactivity of EL-246 at the protein level. 
These data  dearly  establish  that  EL-246 recognizes both 
E-  and Icsdectin. 
Even though many antisdectin mAbs have been developed, 
none have been shown to have the staining characteristics of 
Eb246. CL2, which recognizes human E-sdectin, reacts with 
dog bselectin, but not both proteins in the human (44; C. W. 
Smith, personal communication). Spertini et al. (39) provided 
the functional characterization and molecular localization of 
at least  11 different epitopes on I.~sdectin, but again,  none 
of these are expressed on two different sdectins. TQ-1 and 
Leu-8,  which recognize bsdectin, also show a much more 
restricted pattern of staining and do not stain other selectins 
(M. A. Jutila, unpublished results).  Finally, to our knowl- 
edge, none of the published anti-E-selectin or P-sdectin mAbs 
have been shown to react with other selectins. It is intrigu- 
ing that even though there is a significant  level of identity 
at the amino acid level between different sehctins and a large 
number of antiselectin mAbs have been generated, only Eb 
246 has been reported to recognize a shared epitope. This 
suggests that these sites are not very immunogenic. 
In addition to recognizing E- and L-selectin, we show that 
EL-246 blocks the adhesive functions of both molecules. Lym- 
phocyte adhesion to peripheral lymph node HEV was blocked 
by >95% with EL-246, which was greater than the DREG 
56 anti-bsdectin blocking mAb (88%) 00). In contrast, the 
carbohydrate (PPME) binding activity of bselectin was not 
apparently inhibited by EL-246. EI~246 effectively blocked 
(>90%) the capacity of E-selectin,  expressed in adherent L 
cells, to bind human neutrophils. Additional evidence that 
the EL-246 epitope is of considerable functional importance 
is the conservation of this site in L-selectin from a variety 
of different animals, including humans, goats, sheep, cattle, 
and pigs. We have not examined the conservation of E-sdectin 
in these other animals. 
Insight  into  the  diverse  functional activity of E-  and 
L-sdectin, and the potential "homotypic" interaction of these 
proteins, may be gained by further analysis of the Eb246 epi- 
tope. Neutrophil adhesion to cytokine-activated endothelial 
ceils can be blocked by anti-E-sdectin as well as anti-bselectin 
mAbs (6, 7, 12-14). Kishimoto et al. (15) showed that cer- 
tain anti-E- and -bselectin mAbs are not additive in their 
blocking effects on neutrophil-activated endothelial cell adhe- 
sion, suggesting that these two proteins participate in the 
same adhesion pathway, perhaps as receptor-counter-receptor 
pairs. This hypothesis was supported by the observation that 
neutrophil binding to E-selectin cDNA-transfected L cells is 
blocked by anti-L-sdectin mAb treatment of the leukocyte 
(15). Picker et al.  (16) extended these findings by demon- 
strating that L-selectin on neutrophils is decorated by sLex 
carbohydrates and may preferentially present these structures 
to E-selectin. In contrast, Spertini et al. (14) have also demon- 
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strated that neutrophil-activated endothelial cell adhesion in- 
volves E- and bsdectin, but they found that mAbs to these 
proteins have additive blocking effects, suggesting separate 
adhesion pathways.  Since EL-246 is an effective blocker of 
E- and L-sdectin function and recognizes a different molec- 
ular region (see below) than the blocking mAbs used in the 
above studies, it may be useful in determining the basis for 
some of the discrepancies in the different reports. 
Preliminary domain mapping studies using bselectin/P- 
selectin chimeric proteins that have been used in mapping 
other I.-selectin epitopes (29) localized the EL-246 epitope to 
the SCR domains of lcselectin.  Although we have not per- 
formed analogous studies with E-selectin, it seems likely that 
the epitope defined by EL-246 also resides within the SCR 
domains of this selectin. The location of the EI.-246 epitope 
in the SCRs is supported by the inability of EL-246 to block 
carbohydrate (PPME)  binding and cross-block  antiselectin 
mAbs that recognize the L-selectin  lectin domain. Our studies 
are consistent with recent reports showing that the SCK do- 
mains of IT and E-selectin are essential for optimal adhesive 
activity of each molecule (32, 46). As mentioned in the in- 
troduction, the lectin domain of the selectins is required for 
function, and many blocking antiselectin mAbs recognize 
epitopes encoded by this region (28-30). Previously, we and 
others have localized epitopes for mAbs that inhibit adhe- 
sion mediated by I.,selectin to the EGF domain (25, 29, 31). 
The data presented here extend those observations and dem- 
onstrate that mAbs to appropriate epitopes within each sdectin 
extracellular  domain can inhibit adhesive function. 
It remains unclear whether mAbs that inhibit adhesion 
do so as a result of direct interference with ligand binding 
or if binding ofmAbs, especially those mAbs that define epi- 
topes outside the lectin domain, might perturb the confor- 
mation of the protein so as to indirectly impair the func- 
tional integrity of the lectin domain. If EL-246 blocks by 
altering the functional conformation of the selectins,  this 
would suggest that the role of the SCKs in adhesion is similar 
for E- and Icselectin. This is in contrast to Watson et al. (32), 
who predicted that the role of the SCRs is unique for each 
selectin. Since Eb246 only recognizes E- and L-sdectin, this 
latter prediction may be true for P-selectin.  Thus, in addi- 
tion to having greater numbers of SCR domains (nine vs. 
six and two in E- and bselectin, respectively), there may exist 
molecular differences in P-sdectin SCKs, which contribute 
to the unique functions of this molecule, such as adhesion 
of thrombin-activated platelets. 
In summary, additional molecular and functional charac- 
terization of the EI.,246 epitope will likely lead to new in- 
sights into sdectin function and the evolutionary conserva- 
tion of this family of adhesion proteins.  If this region is 
confirmed to be functionally important, it may provide an 
ideal target for treatments designed to regulate selectin ac- 
tivity in vivo. Importantly, new therapeutics that inhibit or 
alter this site would have the added advantage of blocking 
the activity of leukocyte-endothelial cell adhesion by simul- 
taneously inhibiting both leukocyte as well as endothelial cell 
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